5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Vein Graft Disease
Vein graft disease is a condition that often arises after coronary artery bypass surgery, where a vein from the patient's leg is used to create a bypass around a blocked coronary artery. Over time, these grafts can undergo pathological changes, leading to the development of vein graft disease. The process involves a series of complex events, including inflammation, oxidative stress, and the formation of atherosclerotic plaques within the graft. As vein graft disease progresses, it can compromise blood flow to the heart, ultimately impacting the success of the bypass procedure. Researchers and clinicians focus on understanding the molecular and cellular mechanisms underlying vein graft disease to develop strategies for prevention and intervention, aiming to improve the long-term outcomes of coronary artery bypass grafting procedures.
John R Doty
Intermountain Medical Center, United States
Trevor Tucker
Dynamic Vascular Resolution Inc., Canada
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Fatima Michelle Villa Jimenez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico
Yoana Tenneth Mancilla Sandoval
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing cardiac hospital networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Doppler ultrasound measurement of central artery elasticity: A new natural-frequency framework for cardiovascular risk assessment
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain